IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-3012 on April 15, 2009
(Investigative Ophthalmology and Visual Science. 2009;50:4295-4303.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-3012

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-3012v1
50/9/4295    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenna, K. C.
Right arrow Articles by Singh, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenna, K. C.
Right arrow Articles by Singh, A. D.

Activated CD11b+ CD15+ Granulocytes Increase in the Blood of Patients with Uveal Melanoma

Kyle C. McKenna,1,2 Kelly M. Beatty,1 Richard A. Bilonick,1 Lynn Schoenfield,3 Kira L. Lathrop,1 and Arun D. Singh4

1From the Departments of Ophthalmology and 2Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania; and the 3Department of Anatomic Pathology, and the 4Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.

PURPOSE. To determine whether activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.

METHODS. Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation from the blood of patients with primary choroidal/ciliochoroidal uveal melanomas (six women, four men; age range, 46–91 years) and healthy control donors (14 women, 10 men; age range, 50–81 years). The expression of CD15 and CD68 on CD11b+ myeloid cells within PBMCs and primary uveal melanomas was evaluated by flow cytometry. CD3{zeta} chain expression by CD3{epsilon}+ T cells in PBMCs and within primary uveal melanomas was measured as an indirect indication of T-cell function.

RESULTS. The percentage of CD11b+ cells in PBMCs of patients with uveal melanoma increased 1.8-fold in comparison to healthy donors and comprised three subsets: CD68 negative CD15+ granulocytes, which increased 4.1-fold; CD68 CD15 cells, which increased threefold; and CD68+ CD15low cells, which were unchanged. A significant (2.7-fold) reduction in CD3{zeta} chain expression on CD3{epsilon}+ T cells, a marker of T-cell dysfunction, was observed in PBMCs of patients with uveal melanoma in comparison with healthy control subjects and correlated significantly with the percentage of CD11b+ cells in PBMCs. CD3{zeta} chain expression on T cells within primary tumors was equivalent to CD3{zeta} expression in PBMCs of the same patient in four of five patients analyzed.

CONCLUSIONS. Activated CD11b+ CD15+ granulocytes expand in the blood of patients with uveal melanoma and may contribute to immune evasion by ocular tumors by inhibiting T-cell function via decreasing CD3{zeta} chain expression.





This article has been cited by other articles:


Home page
J VisHome page
M. Day, L. S. Gray, D. Seidel, and N. C. Strang
The relationship between object spatial profile and accommodation microfluctuations in emmetropes and myopes
J Vis, September 1, 2009; 9(10): 5 - 5.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology